Lupin Limited has informed the Exchange about press release dated 08-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules.
Lupin Limited has informed the Exchange about press release dated 08-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules.